Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 2A
Species	Homo sapiens (Human)
Gene	HTR2A
Synonym	5-HT-2 serotonin receptor 2A serotonin 5HT-2 receptor 5-HT-2A 5-HT2A receptor 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 5Ht-2 'D' receptor [ Show all ]
Disease	Depression Unspecified Diabetes Erythropoietic porphyria Fibromyalgia Sleep disorders Schizophrenia Psychiatric disorder Pancreatitis Mood disorder Migraine Hemorrhoids Glaucoma Central nervous system disease Cardiovascular disorder Addiction Schizophrenia; Sleep maintenance insomnia Alcohol use disorders Anxiety disorder [ Show all ]
Length	471
Amino acid sequence	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
UniProt	P28223
Protein Data Bank	6a93, 6a94
GPCR-HGmod model	P28223
3D structure model	This structure is from PDB ID 6a93.
BioLiP	BL0441025,BL0441028, BL0441031, BL0441030,BL0441033, BL0441029,BL0441032, BL0441026, BL0441024,BL0441027
Therapeutic Target Database	T32060
ChEMBL	CHEMBL224
IUPHAR	6
DrugBank	BE0000451

Ligand

Name	pramipexole
Molecular formula	C10H17N3S
IUPAC name	(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
Molecular weight	211.327
Hydrogen bond acceptor	4
Hydrogen bond donor	2
XlogP	1.9
Synonyms	(6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine NC00073 (S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Pramipexole (Mirapex) 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole RT-015572 AB00053772-13 SND 919 B1488 SR-01000763219-6 CPD000449298 Tox21_112445_1 DB00413 FASDKYOPVNHBLU-ZETCQYMHSA-N J-001211 LS-40722 Mirapexin (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole NCGC00167441-03 104632-26-0 Pramipexole Teva 632P260 SC-46343 AB0055235 SpecPlus_000820 CAS-104632-26-0 SUD-919CL2Y CX1349 ZINC3781664 DSSTox_CID_3496 HMS2051A21 KBio2_002340 (-) Pramipexole MLS001423952 (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Pramipexol [Spanish] 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6S)- Pramipexolum A801025 Sifrol(TN) AK-55454 SR-01000763219 SY009549 DB-038042 DTXSID6023496 HSDB 8253 KBioSS_002343 (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine NCGC00167441-01 (S)-Pramipexole Pramipexole (USAN/INN) 2-amino-6-propylaminotetrahydrobenzothiazole s2460 AB00053772_14 SND-919 BDBM50116766 ST24036373 CS-2510 U-98528E DivK1c_006916 FT-0651622 K-0425 Mirapex Mirapexin (TN) (s)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole Oprymea 111GE001 Pramipexole [USAN:INN:BAN] 83619PEU5T SCHEMBL35376 AC1L3P1T Spectrum5_001453 CCG-100823 SUD919CL2Y D05575 DSSTox_GSID_23496 HMS2090C15 KBio2_004908 (-)-Pramipexole MolPort-003-849-957 (S)-N6-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)- Pramipexolum [Latin] AB00053772-12 SMR000449298 ANW-64032 SR-01000763219-5 CHEMBL301265 Tox21_112445 EC 600-593-1 HY-B0410 KS-00000A3W (6S)-N'-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (s)-(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole NCGC00167441-02 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperaziny Pramipexole Base SAM001247006 AB00053772_16 SND-919CL2Y BIDD:GT0250 SUD 919CL2Y CTK8C0068 UNII-83619PEU5T DS-14807 GTPL953 KBio1_001860 Mirapex (TN) MLS000758250 (S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole;(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole Pramipexol 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)- Pramipexole [USAN:INN] Sifrol AJ-45593 Spectrum_001838 CHEBI:8356 SW197453-4 D0G8NN DSSTox_RID_77054 HMS2232B03 KBio2_007476 (6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine [ Show all ]
Inchi Key	FASDKYOPVNHBLU-ZETCQYMHSA-N
Inchi ID	InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1
PubChem CID	119570
ChEMBL	CHEMBL301265
IUPHAR	953
BindingDB	50116766
DrugBank	DB00413
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
	N/A	N/A	DrugBank
Activity	<75.0 %	None	ChEMBL
EC50	1174.9 nM	None	ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417